Processing of Immunosuppressive Pro-TGF-β1,2 by Human Glioblastoma Cells Involves Cytoplasmic and Secreted Furin-Like Proteases

作者: Jens Leitlein , Steffen Aulwurm , Robert Waltereit , Ulrike Naumann , Bettina Wagenknecht

DOI: 10.4049/JIMMUNOL.166.12.7238

关键词:

摘要: TGF-beta is a putative mediator of immunosuppression associated with malignant glioma and other types cancer. Subtilisin-like proprotein convertases such as furin are thought to mediate processing. Here we report that human cell lines express mRNA protein, exhibit furin-like protease (FLP) activity, release active into the culture supernatant. FLP activity not modulated by exogenous or neutralizing Abs. Exposure LN-18 T98G inhibitor, decanoyl-Arg-Val-Lys-Arg-chloromethylketone, inhibits processing TGF-beta1 TGF-beta2 precursor molecules and, consequently, mature bioactive molecules. Ectopic expression PDX, synthetic antitrypsin analog antifurin in cells processing, release. Thus, subtilisin-like may represent novel target for immunotherapy cancers pathological conditions characterized enhanced bioactivity.

参考文章(35)
A. Stieneke-Gröber, M. Vey, H. Angliker, E. Shaw, G. Thomas, C. Roberts, H.D. Klenk, W. Garten, Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. The EMBO Journal. ,vol. 11, pp. 2407- 2414 ,(1992) , 10.1002/J.1460-2075.1992.TB05305.X
W. Schäfer, A. Stroh, S. Berghöfer, J. Seiler, M. Vey, M.L. Kruse, H.F. Kern, H.D. Klenk, W. Garten, Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. The EMBO Journal. ,vol. 14, pp. 2424- 2435 ,(1995) , 10.1002/J.1460-2075.1995.TB07240.X
R Derynck, J A Jarrett, E Y Chen, D V Goeddel, The murine transforming growth factor-beta precursor. Journal of Biological Chemistry. ,vol. 261, pp. 4377- 4379 ,(1986) , 10.1016/S0021-9258(17)38511-3
U V Malipiero, A Fontana, M Schachner, D B Constam, J Philipp, P ten Dijke, Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. Journal of Immunology. ,vol. 148, pp. 1404- 1410 ,(1992)
R. de Martin, B. Haendler, R. Hofer-Warbinek, H. Gaugitsch, M. Wrann, H. Schlüsener, J. M. Seifert, S. Bodmer, A. Fontana, E. Hofer, Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. The EMBO Journal. ,vol. 6, pp. 3673- 3677 ,(1987) , 10.1002/J.1460-2075.1987.TB02700.X
Piotr Jachimczak, Birgit Hessdörfer, Klaus Fabel-Schulte, Cäcilie Wismeth, Wolfgang Brysch, Karl-Hermann Schlingensiepen, Albrecht Bauer, Armin Blesch, Ulrich Bogdahn, Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides. International Journal of Cancer. ,vol. 65, pp. 332- 337 ,(1996) , 10.1002/(SICI)1097-0215(19960126)65:3<332::AID-IJC10>3.0.CO;2-C
Rik Derynck, Julie A. Jarrett, Ellson Y. Chen, Dennis H. Eaton, John R. Bell, Richard K. Assoian, Anita B. Roberts, Michael B. Sporn, David V. Goeddel, Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature. ,vol. 316, pp. 701- 705 ,(1985) , 10.1038/316701A0
F Blanchette, R Day, W Dong, M H Laprise, C M Dubois, TGFbeta1 regulates gene expression of its own converting enzyme furin. Journal of Clinical Investigation. ,vol. 99, pp. 1974- 1983 ,(1997) , 10.1172/JCI119365